[Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation].
D002747:Chlorpropamide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D013997:Time Factors; D014044:Tolbutamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; C009971:glipalamide; D002747:Chlorpropamide
Ocena kliniczna nowej pochodnej sulfonylomocznika--preparatu SPC-703--na podstawie piecioletniej obserwacji.